The Autoimmune Diseases Clinic at CMIT was created with the goal of offering an integrated, specialized, and patient-centered approach to autoimmune diseases. These complex and often multisystemic pathologies require highly differentiated care, capable of combining clinical rigor, up-to-date research, and personalized attention. Our mission is to provide early diagnosis, treatment based on the best scientific evidence, and continuous follow-up, guaranteeing each patient a clear, safe, and effective care pathway. Autoimmune diseases can affect various organs and systems, with very diverse manifestations and varying impact on patients' lives. At the Autoimmunity Clinic, we evaluate and treat a wide spectrum of these conditions, including systemic lupus erythematosus, inflammatory arthritis, Sjögren's syndrome, vasculitis, systemic sclerosis, inflammatory myopathies, Behçet's disease, among others. Our approach is based on three fundamental pillars: diagnostic precision, personalized therapy, and close monitoring of disease progression. The clinical journey at CMIT begins with a detailed and structured assessment, guided by updated protocols and validated instruments for evaluating the activity of autoimmune diseases. This methodology ensures uniformity, reliability, and consistency in the follow-up of our patients over time. Whenever necessary, we collaborate with other medical specialties, guaranteeing a truly multidisciplinary approach, appropriate to the complex nature of these pathologies. The therapeutic component is based on a comprehensive set of options, from conventional immunomodulatory drugs to biological agents and targeted therapies. Treatment is always individualized, considering clinical characteristics, prognostic factors, patient preferences, and impact on quality of life. Safety is a priority: we monitor adverse effects, infectious risk, cumulative toxicity, and drug interactions, ensuring informed and balanced therapeutic decisions. Finally, we value patient education and empowering them to live with a chronic disease. We believe that clear information, consistent communication, and close follow-up are essential to promote therapeutic adherence, recognize warning signs, and improve long-term outcomes. The CMIT Autoimmunity Clinic aims to establish itself as a national benchmark, combining clinical excellence, cutting-edge research, and humane and personalized care. Here, each patient is treated with rigor, science, and dedication.
Medical Staff
The Autoimmune Diseases Clinic at CMIT was created with the goal of offering an integrated, specialized, and patient-centered approach to autoimmune diseases. These complex and often multisystemic pathologies require highly differentiated care, capable of combining clinical rigor, up-to-date research, and personalized attention. Our mission is to provide early diagnosis, treatment based on the best scientific evidence, and continuous follow-up, guaranteeing each patient a clear, safe, and effective care pathway. Autoimmune diseases can affect various organs and systems, with very diverse manifestations and varying impact on patients' lives. At the Autoimmunity Clinic, we evaluate and treat a wide spectrum of these conditions, including systemic lupus erythematosus, inflammatory arthritis, Sjögren's syndrome, vasculitis, systemic sclerosis, inflammatory myopathies, Behçet's disease, among others. Our approach is based on three fundamental pillars: diagnostic precision, personalized therapy, and close monitoring of disease progression. The clinical journey at CMIT begins with a detailed and structured assessment, guided by updated protocols and validated instruments for evaluating the activity of autoimmune diseases. This methodology ensures uniformity, reliability, and consistency in the follow-up of our patients over time. Whenever necessary, we collaborate with other medical specialties, guaranteeing a truly multidisciplinary approach, appropriate to the complex nature of these pathologies. The therapeutic component is based on a comprehensive set of options, from conventional immunomodulatory drugs to biological agents and targeted therapies. Treatment is always individualized, considering clinical characteristics, prognostic factors, patient preferences, and impact on quality of life. Safety is a priority: we monitor adverse effects, infectious risk, cumulative toxicity, and drug interactions, ensuring informed and balanced therapeutic decisions. Finally, we value patient education and empowering them to live with a chronic disease. We believe that clear information, consistent communication, and close follow-up are essential to promote therapeutic adherence, recognize warning signs, and improve long-term outcomes. The CMIT Autoimmunity Clinic aims to establish itself as a national benchmark, combining clinical excellence, cutting-edge research, and humane, personalized care. Here, each patient is treated with rigor, science, and dedication.
The Autoimmune Diseases Clinic at CMIT was created with the goal of offering an integrated, specialized, and patient-centered approach to autoimmune diseases. These complex and often multisystemic pathologies require highly differentiated care, capable of combining clinical rigor, up-to-date research, and personalized attention. Our mission is to provide early diagnosis, treatment based on the best scientific evidence, and continuous follow-up, guaranteeing each patient a clear, safe, and effective care pathway. Autoimmune diseases can affect various organs and systems, with very diverse manifestations and varying impact on patients' lives. At the Autoimmunity Clinic, we evaluate and treat a wide spectrum of these conditions, including systemic lupus erythematosus, inflammatory arthritis, Sjögren's syndrome, vasculitis, systemic sclerosis, inflammatory myopathies, Behçet's disease, among others. Our approach is based on three fundamental pillars: diagnostic precision, personalized therapy, and close monitoring of disease progression. The clinical journey at CMIT begins with a detailed and structured assessment, guided by updated protocols and validated instruments for evaluating the activity of autoimmune diseases. This methodology ensures uniformity, reliability, and consistency in the follow-up of our patients over time. Whenever necessary, we collaborate with other medical specialties, guaranteeing a truly multidisciplinary approach, appropriate to the complex nature of these pathologies. The therapeutic component is based on a comprehensive set of options, from conventional immunomodulatory drugs to biological agents and targeted therapies. Treatment is always individualized, considering clinical characteristics, prognostic factors, patient preferences, and impact on quality of life. Safety is a priority: we monitor adverse effects, infectious risk, cumulative toxicity, and drug interactions, ensuring informed and balanced therapeutic decisions. Finally, we value patient education and empowering them to live with a chronic disease. We believe that clear information, consistent communication, and close follow-up are essential to promote therapeutic adherence, recognize warning signs, and improve long-term outcomes. The CMIT Autoimmunity Clinic aims to establish itself as a national benchmark, combining clinical excellence, cutting-edge research, and humane and personalized care. Here, each patient is treated with rigor, science, and dedication.